Research location
San Donato Milanese
Milano, Italy
Advertisement
Research activity in San Donato Milanese
Milano, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in San Donato Milanese
8 linked trials · page 1 of 1White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's DiseaseNCT06179680 · 2022-07-21 · 1 site observation
RECRUITING
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus GlobalNCT04236609 · 2020-06-15 · 1 site observation
UNKNOWN
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)NCT04210115 · 2020-02-28 · 1 site observation
COMPLETED
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DESNCT03399994 · 2018-05-21 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)NCT03221426 · 2017-10-09 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRINCT01067976 · 2010-02-01 · 1 site observation
COMPLETED
Tarceva Italian Lung Optimization tRialNCT00637910 · 2007-11-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.